Randomised double-blinded phase II AIDS vaccine study comparing immunogenicity and safety of 3 doses of lipopeptide (LIPO-5) [HIV vaccine] versus placebo in non infected HIV volunteers (ANRS VAC 18)
Phase of Trial: Phase II
Latest Information Update: 09 Jul 2010
At a glance
- Drugs Anti-HIV lipopeptide vaccine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 09 Jul 2010 Results have been published in AIDS.
- 05 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.